Articles related to Hematology/Oncology

In light of recent disruptions, it’s crucial for healthcare systems to reconsider how consolidation impacts patient care and to explore diverse value-based care models that prioritize patient outcomes.

In a recent case, symptomatic joint pain and distinctive physical signs in a patient led to the identification of non-small-cell lung cancer, highlighting the critical role of thorough clinical assessment in revealing potential underlying malignancies.

This study introduces a pivotal model that aids physicians in making informed decisions regarding bone marrow sampling for MGUS patients, utilizing a comprehensive set of biomarkers to predict the progression to SMM or worse conditions with high accuracy.

Explore this development in metastatic melanoma treatment with the FDA’s accelerated approval of TIL therapy, a promising approach for patients who have exhausted other options.

The recent uncovering of KSHV’s method of commandeering cell metabolism for cancer progression not only highlights a novel therapeutic target but also emphasizes the need for vigilant monitoring in immunocompromised patients, where such viral activations are more likely to precipitate aggressive cancers.

Imetelstat has shown promising results in improving the quality of life for MDS patients by significantly reducing transfusion dependency, a critical consideration in the management of this blood disorder.